Life Sciences Investors Talk Shop On Asia Opportunities - Singapore Conference
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis launches Option Fund experiment in Korea; Lilly Asian Ventures backs China's life science industry.
You may also be interested in...
GSK Sets Up $500 Million Venture Fund
SR One will become part of new effort that reports to CEO.
Asia Spotlight: Ascendancy Healthcare CEO Sandy Zweifach On The Gap In China
Seeing a gap between the large infrastructure being built in China by multinational and domestic companies, Ascendancy hopes to be an interface to help China access drugs from the West.